* NU Skin Enterprises Inc NUS.N NUS is expected to show
a fall
in quarterly revenue when it reports results on November 2.
* The Provo Utah-based company is expected to report a
11.1% decrease in revenue to $569.812 million from $641.15
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. The company's guidance on
August 4 2022, for the period ended September 30, was for
revenue between $550.00 million and $590.00 million.
* Refinitiv's mean analyst estimate for NU Skin Enterprises
Inc
is for earnings of 78 cents per share. The company's EPS
guidance on August 4 2022, for the period ended September
30, was between USD0.7 and USD0.85
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for NU Skin
Enterprises Inc is $41.5, above its last closing price
of $38.19.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 0.76 0.75 0.77 Beat 2.3
Mar. 31 2022 0.72 0.72 0.76 Beat 5.8
Dec. 31 2021 0.95 0.95 1.11 Beat 17.3
Sep. 30 2021 0.88 0.86 0.97 Beat 12.9
Jun. 1.06 1.05 1.15 Beat 10
30 2021
Mar. 31 2021 0.73 0.72 0.91 Beat 26
Dec. 31 2020 1.18 1.19 1.40 Beat 17.9
Sep. 30 2020 1.03 0.98 1.08 Beat 10.7
This summary was machine generated November 1 at 02:04 GMT. All
figures in US dollars unless otherwise stated